Reply

Journal of the American College of Cardiology

Volumn 47, Issue 9, 2006, Pages 1915-

  Rosenzweig, Erika Berman ^a   Ivy, D Dunbar ^a   Widlitz, Allison ^a   Doran, Aimee ^a   Claussen, Lori R ^a   Yung, Delphine ^a   Abman, Steven H ^a   Barst, Robyn J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN;

DRUG EFFICACY; DRUG FORMULATION; DRUG RESEARCH; DRUG SAFETY; DRUG SOLUBILITY; HUMAN; LETTER; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 33646172949     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.02.012     Document Type: Letter

References (2)

1. Barst R.J., Ivy D., Dingemanse J., et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 73 (2003) 372-382
2. Rosenzweig E.B., Ivy D.D., Widlitz A., et al. Effects of long-term bosentan in children with pulmonary arterial hypertension. J Am Coll Cardiol 46 (2005) 697-706